Sterility Fears Lead to Recall of Vancomycin and Bevacizumab By Avelia

Posted on September 10, 2013

Vancomycin PF (BSS) 1% and Bevacizumab 1.25 mg/0.05 mL PF are being recalled by Avelia Specialty Pharmacy over fears that the sterility of the items cannot be assured.  These compounded products had been sent to Front Range Laboratories for sterility testing, but recent inspections by the Food and Drug Administration have revealed that the practices in place at the facilities may compromise the viability of that testing.  If sterility in fact cannot be guaranteed with the above products, patients exposed to the items could incur a serious infection.  No such incidents have been reported in association with these products at this time, and to ensure that continues, owners are being asked to cease usage and send the medication back to Avelia.

For more about the recall, follow this link.

How Can We Help You?

If you have a legal matter you would like to discuss with an attorney from our firm, please call us at (310) 477-1700 or complete and submit the e-mail form below, and we will get back to you.

  • This field is for validation purposes and should be left unchanged.
  • This field is for validation purposes and should be left unchanged.
*Required Fields